Akebia Therapeutics
AKBA
#7045
Rank
S$0.53 B
Marketcap
$2.45
Share price
1.68%
Change (1 day)
85.06%
Change (1 year)

Akebia Therapeutics (AKBA) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$0.34 Billion

According to Akebia Therapeutics's latest financial reports the company's total liabilities are S$0.34 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Akebia Therapeutics - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.35 B-23.54%
2022-12-31S$0.47 B-23.6%
2021-12-31S$0.61 B17.35%
2020-12-31S$0.52 B3.36%
2019-12-31S$0.50 B3.02%
2018-12-31S$0.49 B52.41%
2017-12-31S$0.32 B-3.77%
2016-12-31S$0.33 B1888.55%
2015-12-31S$16.89 M84.82%
2014-12-31S$9.13 M84.5%
2013-12-31S$4.95 M-17.72%
2012-12-31S$6.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$112.24 B 32,723.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$80.90 B 23,559.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$145.60 B 42,478.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.35 B 3.82%๐Ÿ‡บ๐Ÿ‡ธ USA